臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"pei jer chen"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 401-425 / 883 (共36頁)
<< < 12 13 14 15 16 17 18 19 20 21 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-07-03T03:34:44Z	A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese	Tsai F.-J.; Yang C.-F.; Chen C.-C.; Chuang L.-M.; Lu C.-H.; Chang C.-T.; Wang T.-Y.; Chen R.-H.; Shiu C.-F.; Liu Y.-M.; Chang C.-C.; PEI-JER CHEN; Chen C.-H.; Fann C.S.J.; Chen Y.-T.; Wu J.-Y.
臺大學術典藏	2021-07-03T03:34:44Z	The evolution of real-time PCR machines to real-time PCR chips	Lee D.; PEI-JER CHEN; Lee G.-B.
臺大學術典藏	2021-07-03T03:34:44Z	Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "I"	Yu H.; Yuan Q.; Ge S.-X.; Wang H.-Y.; Zhang Y.-L.; Chen Q.-R.; Zhang J.; PEI-JER CHEN; Xia N.-S.
臺大學術典藏	2021-07-03T03:34:43Z	Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection	Yang H.-I.; Sherman M.; Su J.; PEI-JER CHEN; Liaw Y.-F.; Iloeje U.H.; Chen C.-J.
臺大學術典藏	2021-07-03T03:34:43Z	Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population	Tassaneeyakul W.; Tiamkao S.; Jantararoungtong T.; PEI-JER CHEN; Lin S.-Y.; Chen W.-H.; Konyoung P.; Khunarkornsiri U.; Auvichayapat N.; Pavakul K.; Kulkantrakorn K.; Choonhakarn C.; Phonhiamhan S.; Piyatrakul N.; Aungaree T.; Pongpakdee S.; Yodnopaglaw P.
臺大學術典藏	2021-07-03T03:34:43Z	No increase in prevalence of hepatitis B Surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization	Hsu H.-Y.; Chang M.-H.; Ni Y.-H.; Chiang C.-L.; Chen H.-L.; Wu J.-F.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:42Z	Combining antiangiogenic therapy with immunotherapy exerts better therapeutical effects on large tumors in a woodchuck hepatoma model	Huang K.-W.; Wu H.-L.; Lin H.-L.; Liang P.-C.; PEI-JER CHEN; Chen S.-H.; Lee H.-I.; Su P.-Y.; Wu W.-H.; Lee P.-H.; Hwang L.-H.; Chen D.-S.
臺大學術典藏	2021-07-03T03:34:42Z	Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model	Lin Y.-J.; Huang L.-R.; Yang H.-C.; Tzeng H.-T.; Hsu P.-N.; Wu H.-L.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏	2021-07-03T03:34:42Z	HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses	Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; Chen C.-L.; Kao J.-H.; Lai M.-Y.; Liu C.-H.; Su T.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; PEI-JER CHEN; Liu C.-J.; Chen D.-S.
臺大學術典藏	2021-07-03T03:34:41Z	Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: Long-term predictors from a community-based cohort study	Lee M.-H.; Yang H.-I.; Lu S.-N.; Jen C.-L.; Yeh S.-H.; Liu C.-J.; PEI-JER CHEN; You S.-L.; Wang L.-Y.; Chen W.J.; Chen C.-J.
臺大學術典藏	2021-07-03T03:34:41Z	A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients	Yang T.-S.; Lu S.-N.; Chao Y.; Sheen I.-S.; Lin C.-C.; Wang T.-E.; Chen S.-C.; Wang J.-H.; Liao L.-Y.; Thomson J.A.; Wang-Peng J.; PEI-JER CHEN; Chen L.-T.
臺大學術典藏	2021-07-03T03:34:41Z	Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C	Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:40Z	Eastern asian expert panel opinion: Designing clinical trials of molecular targeted therapy for hepatocellular carcinoma	Yeo W.; PEI-JER CHEN; Furuse J.; Han K.-H.; Hsu C.; Lim H.-Y.; Moon H.; Qin S.; Yeoh E.-M.; Ye S.-L.
臺大學術典藏	2021-07-03T03:34:40Z	Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf	Chen K.-F.; Tai W.-T.; Huang J.-W.; Hsu C.-Y.; Chen W.-L.; Cheng A.-L.; PEI-JER CHEN; Shiau C.-W.
臺大學術典藏	2021-07-03T03:34:40Z	CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells	Chen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; Liu T.-H.; Hou D.-R.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏	2021-07-03T03:34:40Z	Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3	Chen K.-F.; Tai W.-T.; Liu T.-H.; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏	2021-07-03T03:34:39Z	Establishment of a knock-in mouse model with the SLC26A4 c.919-2a>G mutation and characterization of its pathology	Lu Y.-C.; Wu C.-C.; Shen W.-S.; Yang T.-H.; Yeh T.-H.; PEI-JER CHEN; Yu I.-S.; Lin S.-W.; Wong J.-M.; Chang Q.; Lin X.; Hsu C.-J.
臺大學術典藏	2021-07-03T03:34:39Z	Role of microRNAs in hepatitis B virus replication and pathogenesis	Liu W.-H.; Yeh S.-H.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:39Z	DNA detection using commercial mobile phones	Lee D.; Chou W.P.; Yeh S.H.; PEI-JER CHEN; Chen P.H.
臺大學術典藏	2021-07-03T03:34:39Z	Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses	Yeh M.-L.; Hung C.-H.; Huang J.-F.; Liu C.-J.; Lee C.-M.; Dai C.-Y.; Wang J.-H.; Lin Z.-Y.; Lu S.-N.; Hu T.-H.; Yu M.-L.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏	2021-07-03T03:34:38Z	Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan	Mah Y.-H.; Hsu C.-S.; Liu C.-H.; Liu C.-J.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:38Z	Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A	Chen K.-F.; Yu H.-C.; Liu C.-Y.; Chen H.-J.; Chen Y.-C.; Hou D.-R.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏	2021-07-03T03:34:38Z	Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells	Chen K.-F.; Chen H.-L.; Tai W.-T.; Feng W.-C.; Hsu C.-H.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏	2021-07-03T03:34:38Z	Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy	Tseng T.-C.; Yu M.-L.; Liu C.-J.; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; Liu C.-H.; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:37Z	Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma	Shao Y.U.-Y.; PEI-JER CHEN; Lin Z.-Z.; Huang C.-C.; Ding Y.-H.; Lee Y.-H.; Hsu C.-H.; Cheng A.-L.

顯示項目 401-425 / 883 (共36頁)
<< < 12 13 14 15 16 17 18 19 20 21 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2822924
	造訪人次 : 30015157 線上人數 : 1049 教育部委託研究計畫計畫執行:國立臺灣大學圖書館